Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 5, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

[Recent research developments in polymyositis/dermatomyositis].

Naoko Okiyama1, Hitoshi Kohsaka

  • 1Department of Dermatology, Tokyo Medical and Dental University.

Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|May 1, 2008
PubMed
Summary

Idiopathic inflammatory myopathies, polymyositis (PM) and dermatomyositis (DM), are systemic autoimmune diseases with unclear pathology. Research suggests they may represent a disease spectrum, necessitating further investigation into their relationship and underlying mechanisms.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basophil activation to β'-component in adult-onset, salmon roe-induced anaphylaxis.

The journal of allergy and clinical immunology. Global·2026
Same author

Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers.

Rheumatology advances in practice·2026
Same author

Anti-SAE Antibody-Positive Dermatomyositis Presenting With Widespread Erythema Complicated by Rosai-Dorfman Disease.

The Journal of dermatology·2026
Same author

Development of enzyme-linked immunosorbent assays for the detection of myositis-specific autoantibodies against signal recognition particle, nuclear matrix protein 2, and small ubiquitin-like modifier activating enzyme.

Modern rheumatology·2026
Same author

Recombinant human soluble thrombomodulin prevents murine sclerodermatous chronic graft-versus-host disease.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.

Clinical and experimental rheumatology·2025

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Context:

  • Idiopathic inflammatory myopathies, including polymyositis (PM) and dermatomyositis (DM), are systemic autoimmune diseases with incompletely understood pathology.
  • Previous research suggested distinct immunological drivers for PM (cytotoxic T cells) and DM (CD4 T cells, humoral immunity), but histological findings often overlap.
  • Amyopathic dermatomyositis further complicates classification, suggesting a potential spectrum of illness encompassing muscle-only or skin-only disease.

Purpose:

  • To review and synthesize existing clinical and basic research on the pathology of polymyositis and dermatomyositis.
  • To clarify the relationship between PM and DM, considering their potential overlap and shared disease spectrum.
  • To explore the roles of T cells, B cells, and cytokines in the pathogenesis of these myopathies.

Related Experiment Videos

Last Updated: Jul 5, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Summary:

  • The pathology of idiopathic inflammatory myopathies like polymyositis (PM) and dermatomyositis (DM) remains unclear, with overlapping histological features challenging distinct classification.
  • While past research indicated different immune responses in PM (cytotoxic T cells) versus DM (CD4 T cells, humoral immunity), the diseases may exist on a spectrum, including amyopathic DM.
  • This review examines current knowledge of PM/DM pathology, focusing on T cells, B cells, and cytokines, highlighting the need for further research due to limited studies compared to other rheumatic diseases.

Impact:

  • This review aims to consolidate current understanding and identify research gaps in the pathology of polymyositis and dermatomyositis.
  • Clarifying the relationship between PM and DM could lead to improved diagnostic criteria and treatment strategies for these rare rheumatic diseases.
  • Understanding the immunological underpinnings, including T cell and B cell involvement, is crucial for developing targeted therapies for idiopathic inflammatory myopathies.